期刊
BLOOD
卷 129, 期 21, 页码 2864-2872出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2016-11-709873
关键词
-
类别
资金
- National Institutes of Health, National Heart, Lung, and Blood Institute [P01 HL110860]
Heparin-induced thrombocytopenia (HIT) is an immune complication of heparin therapy caused by antibodies to complexes of platelet factor 4 (PF4) and heparin. Pathogenic antibodies to PF4/heparin bind and activate cellular Fc gamma RIIA on platelets and monocytes to propagate ahypercoagulable state culminating in life-threatening thrombosis. It is now recognized that anti-PF4/and laboratory findings have also been recently harnessed for disease prevention. This review will summarize our current understanding of HIT by reviewing pathogenesis, essential clinical and laboratory features, and management.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据